Skip to main content
OpenTrials
Completed

NCT Number: NCT02479503

Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey

The study focuses on the antibiotic prophylaxis use in adult heart transplantation in France.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Antibiotic Prophylaxis Adult Heart Transplantation

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Caen University Hospital

Caen, Normandy, 14000, France

About this study

In adult heart transplantation, clinical situations differ between patients (elective, emergency, redux surgery, ventricular assisting device or extracorporeal live saving). At investigator's knowledge, there is not recommendations in France about antibiotic prophylaxis in adult heart transplantation. So, investigators aimed to study the antibiotic prophylaxis use in adult heart transplantation in France.

Investigators conduct a French national survey about antibiotic prophylaxis used in adult heart transplantation center. Clinical situations such as elective, emergency, redux surgery, ventricular assisting device or extracorporeal live saving are investigated.

Study was performed after Institutional approval was obtained from the local Ethics Committee (Comite de Protection des Personnes Nord Ouest III). An electronic survey was sent to all French adult heart transplantation centers (22) on march 1st, 2015. Reminders were planned on week 2 and 4 after initial sending. On june 2015, nonresponding centers were contacted by phone. Data were collected by a single investigator.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All French centers performing adult heart transplantation in 2015

Exclusion criteria

  • not responding center
  • no adult heart transplantation

Treatment and study plan

Antibiotic prophylaxis in adult heart transplantation

Procedure

Primary outcomes

  1. Class of antibiotic used as prophylaxis in adult heart transplantation

    Time frame: one year

Secondary outcomes

  1. Class of antibiotic used as prophylaxis in adult heart transplantation in regard to clinical situation

    Time frame: one year

    elective, emergency, redux surgery, ventricular assisting device or extracorporeal live saving

  2. Fungal prophylaxis in adult heart transplantation

    Time frame: one year

  3. Other prophylactic measures (isolation, specific room, family visits) used in adult heart transplantation

    Time frame: one year

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Acronym: ATC

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Jun 24, 2015
Registry last updated
Apr 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.